The news will intensify pressure on Pfizer Chief Executive Officer Albert Bourla, who has repeatedly pointed to the drugmaker ...

Pfizer has made competing in the obesity market central to its post-Covid comeback plan. As demand for coronavirus vaccines ...

Pfizer is halting development of its experimental weight-loss pill, as the booming obesity drug market remains out of reach ...

Pfizer has made competing in the obesity market central to its post-Covid comeback plan. As demand for coronavirus vaccines ...

With the discontinuation of danuglipron, Pfizer is now down to one clinical-stage obesity asset: the oral GIP analog ...

Danuglipron: According to the company's latest statement, one patient experienced a potential liver injury that may have been ...

Here's why the stock is worth considering today. The Trump administration has so far exempted pharmaceuticals from its announced tariffs, but the industry has faced repeated threats of future tariffs.

Dividend-paying stocks have consistently attracted investor interest due to their long-term value. CNBC highlights this by ...

We recently published a list of the 11 Best Dividend Paying Stocks According to Hedge Funds. In this article, we are going to ...

Pfizer (PFE) stock slips as the company halts development of danuglipron for weight loss due to liver injury concerns. Read ...